This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial.
Human reproduction (Oxford, England), 40(7), 1357-1365
Citation
Chi, Hongbin; Song, Ying; Jin, Lei; Song, Xueru; Wang, Xiaohong; Ma, Qianhong; Cao, Yunxia; Liang, Xiaoyan; Tan, Jichun; Guan, Yichun; Diao, Feiyang; Li, Yanping; Li, Zeli; Sun, Yuqi; Shu, Chang; Chen, Hong; Shen, Kai; Qiao, Jie. (2025). SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial.. Human reproduction (Oxford, England), 40(7), 1357-1365. https://doi.org/10.1093/humrep/deaf082